RCE 5.26% 60.0¢ recce pharmaceuticals ltd

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-5

  1. 1,426 Posts.
    lightbulb Created with Sketch. 252
    Indeed, but CRs and government grants have always been the sole income stream for RCE and, in my view, always will be. I agree with your available options assessment, however;

    • raises more cash - this I see as their only viable strategy - as long as the shareholders are willing to keep putting their hands in their pockets
    • is bought out - who would buy it at this stage? They have nothing proven of value, just the vague promise of 'new' technology
    • enters into some form of arrangement with a large pharma - if, and when, they develop something that can make money - 'til then, no chance. Curative treatments hold little appeal for pharmaceuticals

    Fortunately for Mr Graham, there are probably enough hopefuls and true believers to keep the gravy train chugging a while longer.
    Last edited by Rykster: 30/01/24
 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
(20min delay)
Last
60.0¢
Change
0.030(5.26%)
Mkt cap ! $122.3M
Open High Low Value Volume
56.5¢ 62.0¢ 56.5¢ $158.1K 263.8K

Buyers (Bids)

No. Vol. Price($)
1 77741 60.0¢
 

Sellers (Offers)

Price($) Vol. No.
61.0¢ 30000 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.